Top compounds associated with response to LRTM2


Feature Type Standardized
Nominal ANOVA
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.093 0.003
mRNA Erlotinib gCSI pan-cancer AAC -0.16 0.003
mRNA A-770041 GDSC1000 pan-cancer AAC -0.15 0.003
mRNA tivantinib CTRPv2 pan-cancer AAC 0.13 0.003
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.004
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.085 0.005
mRNA Platin CTRPv2 pan-cancer AAC 0.1 0.005
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.099 0.005
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.005
Download CSV